MIB

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
Tuesday, April 2, 2024

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

Midea Canada Expands Operations with Move to New 10,000 Sq. Feet Office, Reinforcing Commitment to the Canadian Market

Retrieved on: 
Monday, April 8, 2024

This strategic move is in response to the increasing market needs and underscores our commitment to providing unparalleled support to our stakeholders in Canada.

Key Points: 
  • This strategic move is in response to the increasing market needs and underscores our commitment to providing unparalleled support to our stakeholders in Canada.
  • Lewis, alongside the regional team – Kelly Yu, Mark Tang, Fred Xia, and Evan Guo joined the celebration of this momentous occasion.
  • Philip Xie, General Manager, Midea Canada, expressed his excitement about the relocation, stating, "Our customers are at the heart of everything we do.
  • In 2023, Midea generated an annual revenue exceeding USD 51 billion, underscoring its position as a key player in the home appliance industry.

Quintus Extends Portfolio of Solid-State Battery Presses with Compact MIB 120 Laboratory Model

Retrieved on: 
Tuesday, February 27, 2024

VÄSTERÅS, Sweden, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Isostatic pressure has been shown to be a key process to ensure solid-state battery performance. This has now led to Quintus Technologies' introduction of a small-footprint isostatic battery press for the laboratory environment. The new system, the MIB 120, has been specifically designed to meet the needs of the research community, with its space-saving profile and minimal need for additional infrastructure. The new press has been engineered to deliver results consistent with larger Quintus battery presses, an invaluable capability for universities and institutes engaged in basic research, feasibility, and prototyping studies of Isostatic Battery Pressing.

Key Points: 
  • This has now led to Quintus Technologies' introduction of a small-footprint isostatic battery press for the laboratory environment.
  • The new press has been engineered to deliver results consistent with larger Quintus battery presses , an invaluable capability for universities and institutes engaged in basic research, feasibility, and prototyping studies of Isostatic Battery Pressing.
  • --Jan Söderström, CEO and President, Quintus Technologies
    "We listened to the cell design engineers and developed the MIB 120 press accordingly," says Peter Henning, Director, Marketing and Sales, Quintus Technologies.
  • The MIB 120 can reach pressures of 600 MPa (87,022 psi) and temperatures of 140° C (284° F), which are fully scalable parameters for industrial presses from Quintus Technologies.

Wallbridge Demonstrates Potential to Expand Gold Resources and Commences 2024 Drill Program at Fenelon

Retrieved on: 
Wednesday, February 7, 2024

TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) today announced final results from the 2023 drill program that add near-surface mineralization adjacent to the Fenelon mineral resource and expand the mineralized area to the north and east at its 100%-owned Fenelon Gold project (“Fenelon”).

Key Points: 
  • TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) today announced final results from the 2023 drill program that add near-surface mineralization adjacent to the Fenelon mineral resource and expand the mineralized area to the north and east at its 100%-owned Fenelon Gold project (“Fenelon”).
  • The 2024 drill program has commenced at Fenelon with the objective to expand the limits of near-surface gold resources in the vicinity of the 2023 Preliminary Economic Assessment (“PEA”) mine design, offering the potential to improve the project’s overall economics.
  • In both zones, positive drilling results, presented below, successfully expanded zones of known gold mineralization, further supporting the potential to increase gold resources.
  • At Target F5, east of the Fenelon deposit, the drill holes continued to test favorable host rocks and gold-bearing structures encountered by previous drill programs.

Joel Madden Joins MIB Agents As Brand Ambassador

Retrieved on: 
Wednesday, November 15, 2023

BARNARD, Vt., Nov. 15, 2023 /PRNewswire/ -- Joel Madden, American singer and lead vocalist of Good Charlotte, has officially joined MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to making it better for its community of patients, families, doctors and researchers, as a Brand Ambassador.

Key Points: 
  • Last year, Joel won $200,000 on Celebrity Wheel of Fortune and donated all of his earnings to MIB Agents.
  • In his role as MIB Agents brand ambassador, Joel will raise awareness about MIB Agents' various fundraisers, programs, and community of families with his large audience to help move research forward for osteosarcoma.
  • "We are honored to have Joel Madden join the MIB Agents team to help raise awareness of the work our nonprofit organization is doing to make it better for our community of patients and families," said Ann Graham, Founder and Executive Director of MIB Agents.
  • To listen to Joel Madden's MIB Agents podcast episode, please click here .

MIB Agents Now Accepting Applications for Annual OutSmarting Osteosarcoma Research Grants

Retrieved on: 
Thursday, October 26, 2023

BARNARD, Vt., Oct. 26, 2023 /PRNewswire/ -- MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, families, medical professionals, researchers, and industry partners, is accepting applications for its annual OutSmarting Osteosarcoma research grant program. This program was established in 2017 and is awarded to projects focused on moving research forward for osteosarcoma patients. Osteosarcoma is an aggressive, malignant primary bone cancer affecting an estimated 1,000 people in the U.S. each year, about half of which are children and teens.

Key Points: 
  • BARNARD, Vt., Oct. 26, 2023 /PRNewswire/ -- MIB Agents , a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, families, medical professionals, researchers, and industry partners, is accepting applications for its annual OutSmarting Osteosarcoma research grant program .
  • Over the past seven years, MIB Agents has awarded a total of $1,550,000 and supported 18 investigators to fund promising osteosarcoma research.
  • MIB Agents OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
  • Collaboration among the scientific and patient community is a key hallmark of MIB Agents that makes the OutSmarting Osteosarcoma grant process unique.

India's Pay TV Market is Projected to Register a CAGR of 6.92%, in Terms of Value, Between 2023 & 2027

Retrieved on: 
Monday, July 17, 2023

DUBLIN, July 17, 2023 /PRNewswire/ -- The "Pay TV Market in India 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 17, 2023 /PRNewswire/ -- The "Pay TV Market in India 2023" report has been added to ResearchAndMarkets.com's offering.
  • The pay TV market in India was valued at INR 720.00 Bn in FY 2022.
  • It is expected to reach INR 995.70 Bn by FY 2027, expanding at a compound annual growth rate (CAGR) of 6.92% during the FY 2023 - FY 2027 period.
  • Among the total 357 pay TV channels, there are 165 channels whose maximum retail price (MRP) is less than INR 5.00 per month.

Head of Mobility Institute Berlin Wins Two Business Worldwide Magazine CEO Awards

Retrieved on: 
Thursday, July 13, 2023

LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.

Key Points: 
  • LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.
  • Dr Jörn Richert was the outright winner in two categories: 'Best CEO in the Management Consulting Industry' and 'Growth Strategy CEO of the Year Germany'.
  • The awards seek to identify and celebrate the world's most innovative and influential business leaders, across a wide range of sectors.
  • Unlike other business awards, which focus on the overall work of organisations, here the emphasis is on the C Level executives that lead them.

Head of Mobility Institute Berlin Wins Two Business Worldwide Magazine CEO Awards

Retrieved on: 
Thursday, July 13, 2023

LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.

Key Points: 
  • LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.
  • Dr Jörn Richert was the outright winner in two categories: 'Best CEO in the Management Consulting Industry' and 'Growth Strategy CEO of the Year Germany'.
  • The awards seek to identify and celebrate the world's most innovative and influential business leaders, across a wide range of sectors.
  • Unlike other business awards, which focus on the overall work of organisations, here the emphasis is on the C Level executives that lead them.

Head of Mobility Institute Berlin Wins Two Business Worldwide Magazine CEO Awards

Retrieved on: 
Thursday, July 13, 2023

LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.

Key Points: 
  • LONDON, July 13, 2023 /PRNewswire/ -- The head of Mobility Institute Berlin (mib) has won twice in the 2023 Business Worldwide Magazine CEO Awards.
  • Dr Jörn Richert was the outright winner in two categories: 'Best CEO in the Management Consulting Industry' and 'Growth Strategy CEO of the Year Germany'.
  • The awards seek to identify and celebrate the world's most innovative and influential business leaders, across a wide range of sectors.
  • Unlike other business awards, which focus on the overall work of organisations, here the emphasis is on the C Level executives that lead them.